Home>ProductsProducts
Products
Last Products
Products
- Calcipotriol monohydrate
Cas No.:147657-22-5
Specification: GMP/DMF
- Delafloxacin meglumine
Cas No.:352458-37-8
Specification: GMP/DMF
- Dydrogesterone
Cas No.:152-62-5
Specification: GMP/WC/USDMF
- Elafibranor
Cas No.:824932-88-9
Specification: GMP/DMF
- Empagliflozin
Cas No.:864070-44-0
Specification: GMP/DMF
- Fezolinetant
Cas No.:1629229-37-3
Specification: GMP/DMF
- Palbociclib Capsules-100mg/75mg/125mg
Cas No.:
Specification: China GMP, CTD, BE, Zone IVB available
- Dimdazenil Capsules-2.5mg
Cas No.:
Specification: facility US FDA; European GMP certification, Clinical trail Phase I/II/II, Full CTD dossier
- Enzalutamide Capsule-40mg
Cas No.:
Specification: China GMP, Full CTD dossier, BE
- Bedaquiline Fumarate Tablets-100mg
Cas No.:
Specification: CTD dossier, BE ( Authority agency)
- Semaglutide-1mg:1.5ml, 2mg:1.5ml, 4mg:3ml, 6.8mg:3ml, 9.6mg:3ml
Cas No.:
Specification: US FDA to be submitted; Clinical date: Phase I, Phase III (Under process)
- Pretomanid Tablets-200mg
Cas No.:
Specification: CTD dossier, BE ( Authority agency)
- Tirzepatide-2.5mg:0.5ml, 5mg:0.5ml, 7.5mg: 0.5ml, 10mg:0.5ml, 12.5mg: 0.5ml, 15mg: 0.5ml, 10mg:2.4ml, 20mg:2.4ml, 30mg:2.4ml, 40mg:2.4ml, 50mg:2.4ml, 60mg:2.4ml
Cas No.:
Specification: US FDA to be submitted
- Nilotinib Capsules-150mg, 200mg
Cas No.:
Specification: China GMP, EU GMP expect to approval in 2026,CTD, BE& Zone IVB data available
- Ceftriaxone Sodium for Injection
Cas No.:104376-79-6
Specification: 1.0， Uzbekistan register
